Electromed, Inc.
Moat Score — Electromed, Inc.
Total Moat Score
13 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | Electromed holds patents/trademarks on its SmartVest HFCWO technology and FDA 510(k) clearances, plus brand recognition in a narrow niche, but annual IP spend (~$44,000 in fiscal 2025) is modest, suggesting incremental rather than deeply defensible intellectual property. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 3 / 5 | By selling direct-to-patient and billing payers directly rather than going through DME distributors, Electromed captures distributor-level margin, driving an unusually high ~78% gross margin for a device company of its size. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | High gross margins suggest some pricing leverage, but reimbursement rates are ultimately set by Medicare, Medicaid, and private payers, which constrains the company's unilateral pricing power. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | There is no network effect in airway clearance devices; each patient relationship and reimbursement approval stands alone with no increasing returns from additional users. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 2 / 5 | Once a patient is prescribed, trained, and insurance-approved for a specific SmartVest device, there is some practical friction (re-prescription, re-authorization) to switching brands, but it is not prohibitive. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 3 / 5 | The HFCWO homecare market is small, which limits the economic incentive for new entrants to build out a competing direct sales and reimbursement infrastructure, partially protecting Electromed's position even at modest scale. |